AstraZeneca vaccine kills 7 people in the UK only from side effects of blood clots

Hospital officials are holding AstraZeneca (AZ) vaccines at the companion rehabilitation nursing hospital in Buk-gu, Gwangju on the 23rd when the vaccination of AstraZeneca vaccine for nursing hospitals, nursing facility patients, and residents aged 65 or older began. 2021.3.23/News1 © News1 Reporter Hwang Hee-gyu

In the UK alone, 7 people were killed due to the side effects of blood clots (blood clotting) after getting the AstraZeneca vaccine, the Financial Times (FT) of the UK reported on the 2nd (local time).

On the previous day, British health authorities said that in the UK, 18.1 million people were vaccinated, and 30 cases of blood clot side effects were reported, of which 7 people died.

Not only the UK, but also European countries have also reported deaths from side effects of blood clots. Norwegian health officials said six of the 120,000 AstraZeneca vaccinations reported thrombotic side effects, of which four died.

German health officials also said that of the 2.7 million AstraZeneca vaccinations, 31 cases of thrombotic side effects were reported, of which 9 died.

However, UK health authorities recommend vaccination, saying that a causal link between vaccination and blood clots has not been established.

British health officials added that even if a causal relationship is confirmed, vaccination is recommended because the occurrence of blood clots is extremely rare. British health officials say the occurrence of blood clots is between 5 and 15 cases per million.

As reports of blood clots followed, 12 European countries including the Netherlands, Ireland, Denmark, Norway and Bulgaria temporarily suspended vaccination in the middle of last month.

The United States also suggested that AstraZeneca may not be vaccinated. Anthony Pouch, director of the National Institute of Allergy and Infectious Diseases (NIAID), told Reuters that “the United States may not need the Corona 19 vaccine made by AstraZeneca.”

Anthony Pouch, Director of the National Institute of Allergy and Infectious Diseases, USA. © AFP=News1 © News1 Reporter Dongmyeong Woo

“We already have contracts with other vaccine manufacturers to get enough supplies, so even if the US health authorities approve the use of the AstraZeneca vaccine, the US may not need the AstraZeneca vaccine,” he added.

[email protected]

Source